SDC1 and diabetic retinopathy: Previous studies have demonstrated that inhibition of MMPs in retinal endothelial cells can prevent the loss of syndecan-1 under hyperglycemic conditions [12], implicating MMPs in endothelial glycocalyx damage in diabetic retinopathy and other vascular diseases.